Precision Medicine

Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.

NATE demonstrates trust bundle for patient-mediated exchange

The National Association for Trusted Exchange has demonstrated its new NATE Blue Button for Consumers Trust Bundle, which facilitates interoperability for patient-mediated exchange.

QuadraMed, LifeMed ID Form Patient Identity Joint Venture

RESTON, Va.--QuadraMed Corporation today announced the company has entered into a joint venture called “Better Together” with LifeMed ID, Inc

Opening data, empowering consumers

WASHINGTON, D.C.—“This is the year of empowering the connected health ecosystem,” Aneesh Chopra, former U.S. chief technology officer, told attendees during a panel discussion at the 2015 ONC Annual Meeting on Feb. 2.

A vision for the Federal Health IT Strategic Plan

WASHINGTON, D.C.--The Federal Health IT Strategic Plan (2015-2020) is the backbone of many initiatives emerging from the Department of Health and Human Services, including the interoperability roadmap, the precision medicine initiative and the agency’s move toward pay-for-performance, according to speakers at the Office of the National Coordinator’s Annual Meeting on Feb. 2.

Thumbnail

DeSalvo opens ONC's 2015 Annual Meeting

WASHINGTON, D.C.--The healthcare provider community is ready to see a return on their IT investment, said National Coordinator Karen DeSalvo, MD, MPH, MSc, kicking off the 2015 Office of the National Coordinator for Health IT Annual Meeting on Feb. 2.

InterSystems Successfully Completes eHealth Exchange Product Testing to Ensure Interoperability

CAMBRIDGE, Mass.--InterSystems, a global leader in software for connected healthcare, today announced that the InterSystems HealthShare® informatics platform has successfully completed the eHealth Exchange Product Testing Program. 

Disappointing Outcomes But Hope Springs Eternal

Two big issues we face in 2015 are Meaningful Use (MU) and ICD-10—both contentious in that they aren’t measuring up to their promise.

Thumbnail

How to Create a Patient-Centered Medical Home: A Case Study from Coastal Medical

Rhode Island’s first Medicare Shared Savings ACO used several strategies to achieve system-wide change.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.